IVI in the Media

South China Morning Post | The latest coronavirus boosters target Omicron. Are they safe and effective?

Financial News | IVI Director General Jerome Kim: ‘Bill Gates a strong advocate of IVI’

South China Morning Post | Scientists urge people to take second Covid vaccine booster if offered as Omicron continues to spread

Financial Times | Unvaccinated and unprepared, North Korea faces Covid catastrophe

Chosun Ilbo | Jerome Kim, Director General of International Vaccine Institute, named a distinguished professor at Seoul National University

Financial Times | South Korea downgrades Covid to a ‘Class 2’ disease and removes restrictions

South China Morning Post | China was the world’s biggest Covid-19 vaccine exporter. Not any more

The Wall Street Journal | Despite High Covid-19 Case Counts, Asian Nations Learn to Live With the Virus

Barron’s | China Eases Some Covid Testing Rules. It’s a Targeted Approach to Reduce Impact on the Economy.

CNBC | We need to treat Covid as an endemic pathogen and update vaccines: International Vaccine Institute

Financial Times | Beijing digs in to avoid repeating Hong Kong’s Covid mistakes

The Telegraph | Why China and Hong Kong face a devastating new Covid wave

CGTN | Why is China seeing a surge in COVID-19 cases?

Financial Times | Shanghai teeters on the brink of Covid lockdown

ADB Insight | Year of the Vaccine: The Next Steps for Asia and the Pacific to Combat COVID-19

Fortune | Will we all need fourth COVID vaccine booster shots?

The Telegraph | South Korea abandons its successful test and trace system as omicron cases surge

South China Morning Post | Can China’s home-grown mRNA Covid-19 vaccine pass its final tests?

The Guardian | Cuba leads the world in vaccinating children as young as two against Covid

The Telegraph | Vaccine hesitancy among Taiwan’s elderly mars its pandemic performance and prevents reopening

Director General Jerome Kim on The Alex Salmond Show

South China Morning Post | Which vaccines stop Omicron? Search for data moves from labs to real world

CNBC | 2022 will be the ‘year of vaccination,’ says director of vaccine institute

South China Morning Post | As Omicron upends Covid-19 vaccine targets, what will the future look like?

South China Morning Post | Omicron and the Winter Olympics – is China’s zero-Covid strategy up to the challenges?

CBS Mornings | With Omicron on its doorstep, countries in Asia are closing up

National Geographic | Omicron is dodging the immune system—but boosters show promising signs

Khaleej Times | Covid: 96% of people in low-income nations have yet to receive first vaccine dose, says expert

Voice of America | South Korea Showed How to Contain COVID, Now It Will Try to Live With It

China Daily | Experts say countries should remain cautious about reopening borders

South China Morning Post | Next Covid-19 test? Diagnostic blind spots stir visions of bleak midwinter

South China Morning Post | US-China coronavirus vaccine diplomacy heats up but can donations sway allegiances?

The New York Times | How Asia, Once a Vaccination Laggard, Is Revving Up Inoculations

South China Morning Post | Coronavirus: as rich countries turn to big-name booster shots from Pfizer, AstraZeneca, the poor are left with lesser-known rivals like Abdala, Soberana 2

South China Morning Post | Coronavirus: China seeks to develop next-gen vaccines amid trial complications

South China Morning Post | Can China stay ahead as a leading exporter of Covid-19 vaccines?

Maeil Business Newspaper | All music is beautiful in its own way, but Violinist Sang Hee Lee’s music shines a special light

Nature | Six months of COVID vaccines: what 1.7 billion doses have taught scientists

Asian Boss | We Asked Top Vaccine Expert About COVID Vaccine Problems

Bloomberg | Consequences of ‘Huge’ Global Gap in Vaccinations

EIU Perspectives | What does Denmark’s permanent suspension of both the AstraZeneca and Janssen covid-19 vaccines mean for other countries?

Asia Times | Vaccinations in a race against viral variants

Nature | Why COVID vaccines are so difficult to compare

DEVEX | Opinion: COVAX — too big, and too important, to fail

CNN | “Our response needs to be clear, strong, and unified”

South China Morning Post | Coronavirus vaccines will save 2021? Not so fast, here’s what the experts think

Bloomberg | Will the Covid-19 Vaccines Be Effective and Safe?

Asian Boss | Update On COVID-19 Vaccine Price & Schedule From A Leading Vaccine Expert

The Telegraph | ‘If you are not prepared, the virus has found every weakness’: How countries in Asia tamed Covid-19

CGTN | ‘The vaccine itself is not the silver bullet,’ says International Vaccine Institute

Devex | Q&A: Why Jerome Kim is ‘hopeful’ but cautious about distributing a COVID-19 vaccine

Maeil Business Newspaper | IVI Director General Jerome Kim Shares His Thoughts on Resurgence of COVID-19 Outbreaks in S. Korea

Chosun Ilbo | IVI Director General Jerome Kim Shares His Thoughts on Equitable Access of COVID-19 Vaccines

Channel News Asia | On a fast track like never before: The COVID-19 vaccine effort and 5 vital questions

The Economist’s Future of Healthcare Insight Hour | Vaccine development: A race to the finish line

Devex | Q&A: Is COVID-19 helping or hindering progress toward an HIV vaccine?

TED | The trials, tribulations and timeline of a COVID-19 vaccine

Wired Korea | The End of World War C: Peace without Victory?

Asian Boss | World’s Leading Vaccine Expert Fact-Checks COVID-19 Vaccine Conspiracy

Development Today | Why Sweden funds a vaccine institute in Korea and not Oslo-based CEPI

CNBC | Parts of Asia that relaxed restrictions without a resurgence in coronavirus cases did these three things

The Korea Herald | [Herald Interview] ‘Making vaccines accessible is biggest COVID-19 challenge’

CGTN: The Agenda with Stephen Cole | Speed of vaccine trials is ‘unprecedented’

Asian Boss | We Asked The World’s Leading Vaccine Expert About COVID-19 Vaccine

The Guardian | Test, trace, contain: how South Korea flattened its coronavirus curve

BBC World Service: The Inquiry | How do we come out of the lockdown? (13:00)

ANC 24/7 | Int’l Vaccine Institute: 12-18 months reasonable timetable for development of Covid-19 vaccine

Seeker | How Fast Can We Make a Coronavirus Vaccine?

Education City Speaker Series: Flattening the Curve – Global Responses to COVID-19

Wion News | About 70% of vaccines used around the world are made in India: S Korean expert Dr Jerome Kim

South China Morning Post | How long will a coronavirus vaccine take? A Q&A with Jerome Kim, head of the International Vaccine Institute

BBC World News | Jerome Kim: Vaccines are the long-term solution to the pandemic

The Korea Times | Developing vaccine against COVID-19

TRT: Bigger than Five | COVID-19: The World Reacts

South Korea’s fight against coronavirus (CBS News)

NDTV | Top South Korea Doctor On Why He Thinks Coronavirus Is Not A ‘Chinese Virus’

RTE | What South Korea can teach Ireland about fighting Covid-19

Physical distancing should last months, not weeks, says epidemiologist (Yahoo News Canada)

Development of vaccine requires massive investment… international cooperation is needed (Korea Economic Daily)

COVID-19 Pandemic (Arirang TV, 22:50~46:00)

By then, we’ll have a vaccine on our side (Hankyoreh—Korean)

Coronavirus Pandemic: International Vaccine Institute director on how long it will take to develop vaccine (CGTN)

Testing times: Why South Korea’s COVID-19 strategy is working (Al Jazeera English)

Genexine seeks to compress the vaccine timeline

Genexine, Binex to develop COVID-19 vaccine (Korea Biomedical Review)

Genexine, Binex to co-develop coronavirus vaccine GX-19 (Korea Herald)

How close are we to a COVID-19 vaccine? Jerome H. Kim from International Vaccine Institute (Arirang News)

COVID-19 vaccine, drugs on fast track for development: IVI chief (Yonhap News)

Inside the race to find a coronavirus vaccine (Devex)

Chinese students keen for turnaround (China Daily)

China Daily | S. Korea can try out makeshift hospitals, experts say

Director General Jerome Kim for Phoenix TV

Speed and accuracy vital for COVID-19 test kits (Arirang News)

2020 COVID-19 Live Updates: Jerome Kim for tbs eFM

Jerome Kim for KBS WORLD Radio, Korea24 on the COVID-19 outbreak in South Korea

Korea should join efforts in vaccine development to prevent pandemics (JoongAng Ilbo)

Future global health threats

IVI: COVID-19 could linger (Korean)

Jerome Kim for Korea, Factual: “Hong Kong’s handling of COVID-19 outbreak & Prospects of vaccine development”

Concerns about the spread of COVID-19: When will a vaccine be developed? When can we expect the “Super Vaccine”?

Al Jazeera English | Scientists call for global cooperation over coronavirus

When will COVID-19 vaccine be commercialized…And “super vaccine”? (Korean)

Global push to find vaccine against devastating bug growing

IVI receives $15.7 million to conduct Ph III trials of typhoid vaccine

Korean vaccines expanding global territory

Neglected Victims of Neglected Diseases

Let’s build a common defense against epidemics

Vaccine investment brings 16-fold return… partnering with Bill Gates

World must join forces to prevent infectious diseases

IVI editorial in The Korea Herald advocates for Korean leadership for global health


IVI Holds Inauguration Ceremony for New Director General Dr. Jerome H. Kim

2015-06-22 00:00

IVI Holds Inauguration Ceremony for

New Director General Dr. Jerome H. Kim


Dignitaries pose for a photo at the inauguration of the IVI Director General at IVI Headquarters on June 22. The event was attended by more than 100 people, including Dr. Jerome Kim (fourth from left, front row); Prof. Adel A. Mahmoud, Chair of the IVI Board of Trustees (third from left, front row); Lars Danielsson, Swedish Ambassador to Korea (third from left, rear row); Mark Lippert (far right, rear row), U.S. Ambassador to Korea; Dr. Gim Chaechun (second from left, front row), Vice Minister of Education; Prof. Sung Nak-in (third from right, front row), President of Seoul National University; and Prof. Cho Dong-sung, President of the Korea Support Committee for IVI.




 l  Ceremony attended by more than 100 people including donors and partners such as Korean Ministry of Education, Swedish Ambassador to Korea, and the Bill & Melinda Gates Foundation

l  Director General Kim urges partners to “Harness science in the interest of society” and calls for continued support, strengthened partnerships in vaccine research to cope with emerging diseases including MERS and Ebola, as well as neglected diseases such as cholera



June 22, Seoul, South Korea - The International Vaccine Institute (IVI) held an inauguration ceremony for its new Director General Jerome H. Kim, M.D., at the IVI headquarters at Seoul National University today. Dr. Kim began his term in March 2015 and will be leading the Seoul-based international organization for the next four years.


Dr. Kim, who has accumulated a wide range of knowledge and experience as a vaccine development expert and HIV research authority, has been spotlighted as the first IVI leader of Korean descent. Dr. Kim’s appointment as IVI’s leader is expected to add significant momentum to the development of the Institute, the first international organization hosted by the Republic of Korea.


The inauguration ceremony was attended by more than 100 people including IVI donors, stakeholders, and partners. Remarks were given by Prof. Adel A. Mahmoud, Chair of IVI’s Board of Trustees and Professor of Molecular Biology at Princeton University in the U.S.; Gim Chae-Chun, Vice Minister of Education of Korea; Ms. Becky Frank, Deputy Director of Strategy Planning & Management for Enteric & Diarrheal Disease (EDD) and Pneumonia from the Bill & Melinda Gates Foundation; H.E. Lars Danielsson, Swedish Ambassador to Korea; Prof. Sung Nak-In, President of Seoul National University; and Prof. Cho Dong-Sung, President of the Korea Support Committee for IVI (KSC).


In his inaugural speech, Dr. Kim stated, “This ceremony is being held at a time when Korea is battling the Middle East Respiratory Syndrome, or MERS, a disease unknown until 2012…like SARS, influenza, and Ebola the spread of these threats is facilitated by something we all take for granted, the necessity, and ease, of international travel…we must engage with energy and purpose: to identify, understand, and control – to develop treatments and work on prevention, and ultimately, a vaccine. Once again, let’s harness science in the interest of society.”


Vice Minister Gim Chae-Chun, said, “In the wake of the recent outbreak of MERS in Korea and last year's Ebola virus epidemic in West Africa, the global community is becoming ever more aware of the importance of developing and distributing vaccines, which is why it is time for the international community to make concerted efforts under the lead of IVI,” adding, “I'm looking forward to seeing IVI boost capacity in vaccine research and take a new leap forward under Director General Kim’s leadership.”


IVI has been collaborating with a number of vaccine manufacturers in several countries through technology transfer and clinical development to help them bring vaccines to licensure and to obtain WHO prequalification (PQ). In Korea, IVI is partnering with SK Chemicals on a new typhoid vaccine and with EuBiologics on an oral cholera vaccine.


“IVI’s vaccine research has been instrumental in helping to reduce the burden of infectious diseases in developing countries. Their support is helping to elevate the global profile of the Korean vaccine industry and research capabilities to have a positive impact on global health, Ms. Becky Frank of the Gates Foundation said. “As Korean companies have become household names globally for electronic consumer goods, cars and others industries, we can easily envision a future where Korea enjoys the same reputation for vaccines.”


Dr. Kim is among the world’s leading authorities in the field of HIV/AIDS vaccine development. He was named one of “The 50 Most Influential People in Vaccines” in 2014 by the vaccine industry organization Vaccine Nation. Prior to joining IVI, Dr. Kim served as Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis at the U.S. Military HIV Research Program (MHRP) and also as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Material Development Activity. He is a Professor of Medicine at the Uniformed Services University of the Health Sciences, and Fellow of the American College of Physicians and the Infectious Diseases Society of America. He received his M.D. from the Yale University School of Medicine.




About IVI

The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against enteric and diarrheal infections, Japanese encephalitis, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit www.ivi.int.



Media Contact:


IVI Media Contact:


Tae Kyung Byun

Public Awareness/Advocacy Officer, IVI

Phone: +82-2-872-2801 (Ext. 159)

Mobile: +82-10-8773-6071

Email: tkbyun@ivi.int


Burson-Marsteller Korea Contact:

Ayoung Jang

Phone: +82-2-3782-6465

Mobile: +82-10-3596-2440

Email: Ayoung.Jang@bm.com